InspireMD (NSPR) Shares Outstanding (Weighted Average) (2010 - 2025)

InspireMD has reported Shares Outstanding (Weighted Average) for 16 years, with the latest figure at $64.3 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 53.42% year-over-year to $64.3 million; the trailing twelve-month figure through Dec 2025 stood at $64.3 million (up 53.42% YoY), and the FY2025 full-year result was $64.3 million, up 53.42% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $64.3 million, up from $33.7 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $64.3 million in Q4 2025, with the low at $1.8 million in Q1 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $21.4 million across 5 years, with a median of $15.6 million in 2023.
• Annual changes were most pronounced in 2021 — Shares Outstanding (Weighted Average) soared 1886.58% — and 2023, when it sank 77.02%.
• InspireMD's Shares Outstanding (Weighted Average) stood at $7.3 million in 2021, then increased by 7.16% to $7.9 million in 2022, then surged by 208.29% to $24.3 million in 2023, then surged by 72.77% to $41.9 million in 2024, then soared by 53.42% to $64.3 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $64.3 million (Q4 2025), $33.7 million (Q3 2025), and $51.0 million (Q2 2025), per Business Quant data.